Linezolid Krka

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone presented as an oral tablet for systemic use. It treats infections caused by resistant Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), as well as certain community‑acquired pneumonias and skin infections.

GNH USA supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from regulatory support and responsive technical service.

Linezolid is an oxazolidinone antibiotic used to treat serious infections caused by resistant Gram‑positive bacteria.

- Methicillin‑resistant Staphylococcus aureus (MRSA) infections: effective treatment of skin, respiratory and bloodstream infections caused by MRSA. - Vancomycin‑resistant Enterococcus (VRE) infections: provides an option for complicated urinary tract and intra‑abdominal infections where VRE is identified. - Community‑acquired bacterial pneumonia: used when typical pathogens are suspected and resistance to first‑line agents is a concern. - Skin and soft tissue infections: treats complicated cellulitis and abscesses caused by susceptible Gram‑positive organisms.

Linezolid may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial discomfort. - Metallic taste: altered taste sensation.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count requiring monitoring. - Peripheral neuropathy: nerve damage that can be irreversible if not detected early. - Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents.

When prescribing Linezolid, clinicians should consider several safety and handling factors. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic dysfunction: assess liver enzymes regularly during treatment. - Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome. - Prolonged therapy: perform periodic complete blood counts to detect hematologic effects. - Pregnancy and lactation: use only if potential benefit justifies potential risk to fetus or infant. - Store at room temperature: keep in original packaging, protect from moisture and light.

Linezolid interacts with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): may precipitate serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin toxicity. - Tyramine‑rich foods: can cause hypertensive crisis when combined with linezolid.

Moderate Interactions (Monitor Closely): - Warfarin: linezolid may increase INR, requiring dose adjustment. - Rifampin: induces metabolism, potentially lowering linezolid concentrations. - Carbamazepine and other enzyme‑inducing anticonvulsants: may reduce linezolid exposure.